
EFX
Equifax Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
247.215
Open
246.800
VWAP
--
Vol
28.91K
Mkt Cap
30.60B
Low
245.665
Amount
--
EV/EBITDA(TTM)
19.28
Total Shares
123.61M
EV
35.45B
EV/OCF(TTM)
25.51
P/S(TTM)
5.29
Equifax Inc. is a global data, analytics, and technology company. The Company is engaged in helping financial institutions, companies, employers, and government agencies make critical decisions. The Company’s Workforce Solutions segment provides services enabling customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure and sanctions of people in the United States. The Company’s U.S. Information Solutions (USIS) segment provides consumer and commercial information solutions to businesses in the United States, including online information, decisioning technology solutions, identity management services, analytical services, e-commerce fraud and charge back protection services, portfolio management services, mortgage information and marketing services. The Company’s International segment provides products and services similar to those available in the USIS segment but with variations by geographic region.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
1.58B
+9.28%
1.857
+21.38%
1.51B
+6.68%
2.083
-1.75%
1.52B
+5.6%
1.943
+5.02%
Estimates Revision
The market is revising Upward the revenue expectations for Equifax Inc. (EFX) for FY2025, with the revenue forecasts being adjusted by 0.19% over the past three months. During the same period, the stock price has changed by -5.27%.
Revenue Estimates for FY2025
Revise Upward

+0.19%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-0.15%
In Past 3 Month
Stock Price
Go Down

-5.27%
In Past 3 Month
15 Analyst Rating

18.78% Upside
Wall Street analysts forecast EFX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EFX is 292.69 USD with a low forecast of 260.00 USD and a high forecast of 315.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Buy
4 Hold
0 Sell
Moderate Buy

18.78% Upside
Current: 246.415

Low
260.00
Averages
292.69
High
315.00

18.78% Upside
Current: 246.415

Low
260.00
Averages
292.69
High
315.00
Barclays
Manav Patnaik
Equal Weight
downgrade
$260 -> $240
2025-07-23
Reason
Barclays
Manav Patnaik
Price Target
$260 -> $240
2025-07-23
downgrade
Equal Weight
Reason
Barclays analyst Manav Patnaik lowered the firm's price target on Equifax to $240 from $260 and keeps an Equal Weight rating on the shares following the Q2 report. The firm says lending-driven upside did not materialize into raising the high-end of Equifax's earnings guidance due to Workforce Solutions now expected to slow in the second half of the year.
Wells Fargo
Overweight
downgrade
$310 -> $300
2025-07-23
Reason
Wells Fargo
Price Target
$310 -> $300
2025-07-23
downgrade
Overweight
Reason
Wells Fargo lowered the firm's price target on Equifax to $300 from $310 and keeps an Overweight rating on the shares. The firm notes the company maintained guidance ex. FX, despite strong Q2 results, citing elevated macro uncertainty exiting the quarter. Management also guided to a deceleration in Government in the second half of 2025 as it faces near-term headwinds.
Baird
Outperform
to
NULL
downgrade
$310 -> $289
2025-07-23
Reason
Baird
Price Target
$310 -> $289
2025-07-23
downgrade
Outperform
to
NULL
Reason
Baird lowered the firm's price target on Equifax to $289 from $310 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results which saw a surprisng government reduction but shares are now at an attractive entry point.
Oppenheimer
Owen Lau
Outperform
maintain
$296 -> $279
2025-07-23
Reason
Oppenheimer
Owen Lau
Price Target
$296 -> $279
2025-07-23
maintain
Outperform
Reason
Oppenheimer analyst Owen Lau lowered the firm's price target on Equifax to $279 from $296 and keeps an Outperform rating on the shares. The firm notes the company reported a strong second quarter with strong revenue from Verification and Online Information Services for both mortgage and non-mortgage. Despite the beat, management only raised FY25 reported revenue and adjusted EPS guidance midpoint by $35M and 3c, respectively, due to FX. Oppenheimer believes the outlook appears to be challenging because of headwinds to Government vertical, weak hiring environment, and increased litigation and non-recurring severance costs.
BMO Capital
Ryan Griffin
Market Perform
downgrade
$280 -> $260
2025-07-23
Reason
BMO Capital
Ryan Griffin
Price Target
$280 -> $260
2025-07-23
downgrade
Market Perform
Reason
BMO Capital analyst Ryan Griffin lowered the firm's price target on Equifax to $260 from $280 and keeps a Market Perform rating on the shares. Equifax reported a solid quarter given top-line strength in Equifax Workforce Solutions and US Information Solutions, but management lowered its EWS growth forecast given Government and Talent near-term struggles while raising USIS expectations, the analyst tells investors in a research note.
UBS
Kevin McVeigh
Buy
downgrade
$315 -> $278
2025-07-23
Reason
UBS
Kevin McVeigh
Price Target
$315 -> $278
2025-07-23
downgrade
Buy
Reason
UBS analyst Kevin McVeigh lowered the firm's price target on Equifax to $278 from $315 and keeps a Buy rating on the shares.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Equifax Inc (EFX.N) is 30.17, compared to its 5-year average forward P/E of 29.27. For a more detailed relative valuation and DCF analysis to assess Equifax Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair
5Y Average PE
29.27
Current PE
30.17
Overvalued PE
33.56
Undervalued PE
24.99
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair
5Y Average EV/EBITDA
17.72
Current EV/EBITDA
16.78
Overvalued EV/EBITDA
19.63
Undervalued EV/EBITDA
15.82
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
5.14
Current PS
4.74
Overvalued PS
5.85
Undervalued PS
4.43
Financials
Annual
Quarterly
FY2025Q2
YoY :
+7.44%
1.54B
Total Revenue
FY2025Q2
YoY :
+10.13%
310.80M
Operating Profit
FY2025Q2
YoY :
+16.59%
192.60M
Net Income after Tax
FY2025Q2
YoY :
+16.79%
1.53
EPS - Diluted
FY2025Q2
YoY :
+82.65%
238.90M
Free Cash Flow
FY2025Q2
YoY :
+1.89%
45.22
Gross Profit Margin - %
FY2025Q2
YoY :
+27.02%
15.70
FCF Margin - %
FY2025Q2
YoY :
+8.48%
12.53
Net Margin - %
FY2025Q2
YoY :
+2.89%
7.83
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
518.2K
USD
1
3-6
Months
5.7M
USD
1
6-9
Months
5.7M
USD
3
0-12
Months
17.0M
USD
3
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 197.94% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
1.8M
Volume
8
6-9
Months
743.6K
Volume
6
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
8
2.8M
Volume
Months
6-9
11
934.9K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
16.0K
USD
2
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
1
8.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
518.2K
USD
1
3-6
Months
5.7M
USD
1
6-9
Months
5.7M
USD
3
0-12
Months
17.0M
USD
3
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
EFX News & Events
Events Timeline
2025-07-22 (ET)
2025-07-22
06:42:03
Equifax raises FY25 adjusted EPS view to $7.33-$7.63 from $7.25-$7.65

2025-07-22
06:38:25
Equifax sees Q3 adjusted EPS $1.87-$1.97, consensus $1.99

2025-07-22
06:35:47
Equifax reports Q2 adjusted EPS $2.00, consensus $1.91

Sign Up For More Events
Sign Up For More Events
News
4.0
11:30 AMNewsfilterEquifax National Market Pulse Data Shows U.S. Consumers Continuing to Spend, Avoiding Delinquency
9.5
07-29NASDAQ.COMFiserv Q2 Earnings Beat Estimates on Strong Margins, Revenues Miss
7.5
07-28NewsfilterEquifax and Qlarifi Partner to Study Impact of Buy Now, Pay Later on Credit Risk and Fraud
Sign Up For More News
People Also Watch

LVS
Las Vegas Sands Corp
52.950
USD
+1.17%

ROK
Rockwell Automation Inc
352.955
USD
-0.27%

HIG
Hartford Insurance Group Inc
125.190
USD
+0.44%

WTW
Willis Towers Watson PLC
302.550
USD
+0.08%

DECK
Deckers Outdoor Corp
110.640
USD
-1.31%

TPL
Texas Pacific Land Corp
992.640
USD
-0.10%

DD
Dupont De Nemours Inc
73.380
USD
-1.24%

ALNY
Alnylam Pharmaceuticals Inc
337.320
USD
+2.05%

IRM
Iron Mountain Inc
99.184
USD
-0.24%

EXR
Extra Space Storage Inc
151.640
USD
-0.18%
FAQ

What is Equifax Inc (EFX) stock price today?
The current price of EFX is 246.415 USD — it has decreased -0.32 % in the last trading day.

What is Equifax Inc (EFX)'s business?

What is the price predicton of EFX Stock?

What is Equifax Inc (EFX)'s revenue for the last quarter?

What is Equifax Inc (EFX)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Equifax Inc (EFX)'s fundamentals?

How many employees does Equifax Inc (EFX). have?
